Paperpal Prime Logo

eBioMedicine : Impact Factor & More

eISSN: 2352-3964pISSN: 2352-3964
JournalOpen Access

Key Metrics

CiteScore
15
Eigenfactor
0.01 - 0.05
Impact Factor
10 - 15
Scite Index
0.91 5-Year SI
SJR
Q1Biochemistry, Genetics and Molecular Biology (all)
SNIP
1.99
Recommended pre-submission checks
Powered by Paperpal by Editage

Topics Covered on eBioMedicine

eBioMedicine Journal Specifications

Indexed in the following public directories

  • Web of Science Web of Science
  • Scopus Scopus
  • DOAJ DOAJ
  • SJR SJR
Overview
Publisher ELSEVIER
Language English
Frequency Monthly
Article Processing ChargesUSD 5000
Publication Time5
Editorial Review ProcessAnonymous peer review
General Details
LanguageEnglish
FrequencyMonthly
Publication Start Year2013
Publisher URLVisit website
Website URLVisit website
Publication Details
Other chargesVisit website
PlagiarismVisit website
Publication Time 5
Waiver PolicyVisit website
Editorial Review Detail
Editorial TeamVisit website
Review ProcessAnonymous peer review
Review UrlVisit website
Information for authors
Author instructionsVisit website
Copyright DetailsVisit website
License typeCC BY, CC BY-NC-ND
OA statementVisit website
View less

Planning to publish in eBioMedicine ?

Upload your Manuscript to get

  • Degree of match
  • Common matching concepts
  • Additional journal recommendations
Free Report

Recently Published Papers in eBioMedicine

Early pregnancy GDF15 trajectories and their association with normal gestation, pregnancy loss, and hyperemesis gravidarum.
  • 6 Aug 2026
  • EBioMedicine
Immunodominance hierarchy of influenza A haemagglutinin antigenic sites: an observational cohort study across distinct exposure histories.
  • 6 Aug 2026
  • EBioMedicine
Joint profiling of immune-endothelial cells in sepsis: promise, pitfalls, and the path forward.
  • 5 Aug 2026
  • EBioMedicine
Data-driven trajectories of atrophy explain clinical heterogeneity across Lewy body diseases.
  • 5 Aug 2026
  • EBioMedicine
Lesion viral burden, multidrug-resistant superinfection, and HIV-associated haematological vulnerability in hospitalised clade Ib mpox: a prospective cohort study in Uganda.
  • 5 Aug 2026
  • EBioMedicine
Comparative in vivo evaluation of colistin resistance determinants in Escherichia coli clone ST131.
  • 5 Aug 2026
  • EBioMedicine
Early pregnancy GDF15 trajectories and their association with normal gestation, pregnancy loss, and hyperemesis gravidarum.
  • 6 Aug 2026
  • EBioMedicine
Immunodominance hierarchy of influenza A haemagglutinin antigenic sites: an observational cohort study across distinct exposure histories.
  • 6 Aug 2026
  • EBioMedicine
Joint profiling of immune-endothelial cells in sepsis: promise, pitfalls, and the path forward.
  • 5 Aug 2026
  • EBioMedicine
Data-driven trajectories of atrophy explain clinical heterogeneity across Lewy body diseases.
  • 5 Aug 2026
  • EBioMedicine
Lesion viral burden, multidrug-resistant superinfection, and HIV-associated haematological vulnerability in hospitalised clade Ib mpox: a prospective cohort study in Uganda.
  • 5 Aug 2026
  • EBioMedicine
Comparative in vivo evaluation of colistin resistance determinants in Escherichia coli clone ST131.
  • 5 Aug 2026
  • EBioMedicine

FAQs on eBioMedicine